In the present study, we combined a gene expression analysis of HuR-silenced cells and a bioinformatics-based selection procedure to uncover putative mRNAs regulated by HuR in Hs578T human basal-like triple-negative breast cancer cells. The gene discussed is ELAVL1; the disease is triple-negative breast carcinoma.